Reilly Owen Loomis, PA
Physician Assistant · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 3
- Since medical school
- 10 years
- Graduated 2016
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Reilly Owen Loomis’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$92,362
Medicare paid this office $92,362 for 338 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 86 | $30,235 | None |
| Aspiration and/or injection of fluid from large joint | 140 | $19,225 | $60 |
| Return visit (30+ min) | 105 | $11,165 | $94 |
| Replacement of thigh bone and hip joint with prosthesis | 38 | $5,862 | $147 |
| Replacement of knee joint, both sides of knee | 38 | $5,780 | $148 |
See all 10 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 86 | $30,235 | None |
| Aspiration and/or injection of fluid from large joint | 140 | $19,225 | $60 |
| Return visit (30+ min) | 105 | $11,165 | $94 |
| Replacement of thigh bone and hip joint with prosthesis | 38 | $5,862 | $147 |
| Replacement of knee joint, both sides of knee | 38 | $5,780 | $148 |
| Short return visit (20+ min) | 54 | $3,846 | $69 |
| New patient visit (30+ min) | 41 | $3,336 | $81 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 12 | $1,455 | $91 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 62 | $224 | None |
| Injection, bupivicaine, not otherwise specified, 0.5 mg | 13 | $2 | None |
Procedures Medicare counted
| Hip replacement | 1-10 | None |
| Knee replacement | 11 | More than 37% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | 70 | 91 | 130 | 325 | 335 | 320 |
| Replacement of knee joint, both sides of knee | 34 | 32 | 31 | 45 | 73 | 39 |
| Replacement of thigh bone and hip joint with prosthesis | 16 | 34 | 47 | 40 | 38 | 40 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 24 | – | – | – | 21 | 16 |
| Aspiration and/or injection of fluid from medium joint | – | – | – | – | 12 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
338 Original Medicare patients in 2024. Average age 76 · Women 66% · Also on Medicaid 5% · Health risk score 0.87. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 66% · Coronary heart disease 20% · Diabetes 19% · Chronic kidney disease 17% · Atrial fibrillation 17% · Depression 17% · Cancer 15% · Heart failure 7% · Stroke 7% · COPD 6% · Dementia 4%.
The office billed $554,969, Medicare allowed $120,681 and paid $92,362; for 2,192 services of 30 kinds; $37,465 of it was for drugs given in the office and $54,897 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 338 | 2,192 | 76 | 0.87 | $554,969 | $92,362 |
| 2023 | 386 | 1,818 | 77 | 0.92 | $530,124 | $96,611 |
| 2022 | 341 | 1,383 | 76 | 0.84 | $440,244 | $91,031 |
| 2021 | 194 | 666 | 76 | 0.81 | $246,036 | $44,192 |
| 2020 | 157 | 471 | 75 | 0.81 | $190,971 | $32,603 |
| 2019 | 167 | 616 | 74 | 0.91 | $177,752 | $33,712 |
| 2018 | 199 | 823 | 71 | 0.96 | $186,396 | $39,420 |
| 2017 | 128 | 359 | 71 | 1.12 | $180,269 | $21,785 |
| 2016 | 16 | 21 | 70 | 0.95 | $38,190 | $2,537 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 91 | $31,446 | None |
| Aspiration and/or injection of fluid from large joint | 149 | $19,739 | $59 |
| Replacement of knee joint, both sides of knee | 72 | $10,724 | $147 |
| Return visit (30+ min) | 80 | $9,005 | $97 |
| Short return visit (20+ min) | 81 | $6,297 | $71 |
| Replacement of thigh bone and hip joint with prosthesis | 38 | $5,801 | $153 |
| New patient visit (30+ min) | 68 | $4,975 | $73 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 16 | $1,853 | $88 |
| Aspiration and/or injection of fluid from medium joint | 11 | $500 | $42 |
| Short return visit | 11 | $376 | $34 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 86 | $343 | None |
2022: 9 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 96 | $36,586 | None |
| Aspiration and/or injection of fluid from large joint | 153 | $19,495 | $60 |
| Return visit (30+ min) | 78 | $9,182 | $101 |
| Replacement of knee joint, both sides of knee | 44 | $6,837 | $152 |
| Replacement of thigh bone and hip joint with prosthesis | 40 | $6,041 | $151 |
| Short return visit (20+ min) | 76 | $5,680 | $70 |
| New patient visit (30+ min) | 41 | $3,254 | $79 |
| Short return visit | 21 | $985 | $47 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 73 | $295 | None |
2021: 8 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 52 | $13,939 | None |
| Aspiration and/or injection of fluid from large joint | 72 | $7,858 | $60 |
| Replacement of thigh bone and hip joint with prosthesis | 45 | $7,427 | $158 |
| Replacement of knee joint, both sides of knee | 30 | $4,813 | $155 |
| Return visit (30+ min) | 25 | $3,021 | $104 |
| Short return visit (20+ min) | 37 | $2,888 | $74 |
| New patient visit (30+ min) | 17 | $1,398 | $82 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 25 | $120 | None |
2020: 7 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 30 | $8,897 | None |
| Replacement of thigh bone and hip joint with prosthesis | 33 | $5,738 | $169 |
| Replacement of knee joint, both sides of knee | 30 | $5,393 | $169 |
| Aspiration and/or injection of fluid from large joint | 50 | $5,157 | $57 |
| Short return visit (20+ min) | 35 | $2,262 | $53 |
| New patient visit (30+ min) | 20 | $1,593 | $80 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $102 | None |
2019: 10 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 31 | $9,743 | None |
| Replacement of knee joint, both sides of knee | 34 | $4,882 | $144 |
| Aspiration and/or injection of fluid from large joint | 44 | $4,038 | $58 |
| Return visit (30+ min) | 45 | $3,336 | $64 |
| Short return visit (20+ min) | 28 | $2,382 | $51 |
| Replacement of thigh bone and hip joint with prosthesis | 16 | $2,316 | $145 |
| New patient visit (30+ min) | 20 | $1,422 | $71 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 18 | $1,227 | $51 |
| X-ray of knee, 1-2 views | 16 | $292 | $18 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $105 | None |
2018: 11 services
| Return visit (30+ min) | 100 | $9,687 | $72 |
| Replacement of knee joint, both sides of knee | 52 | $7,519 | $145 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 52 | $4,887 | $63 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 22 | $4,534 | None |
| Short return visit (20+ min) | 29 | $2,461 | $51 |
| Replacement of thigh bone and hip joint with prosthesis | 13 | $1,757 | $135 |
| New patient visit (30+ min) | 22 | $1,389 | $63 |
| X-ray of knee, 1-2 views | 63 | $1,375 | $20 |
| X-ray of hip, 2-3 views | 23 | $821 | $29 |
| X-ray of knee, 3 views | 14 | $380 | $27 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 40 | $244 | None |
2017: 10 services
| Replacement of knee joint, both sides of knee | 37 | $5,334 | $144 |
| Return visit (30+ min) | 38 | $3,113 | $69 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 17 | $2,888 | None |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 27 | $2,372 | $62 |
| Replacement of thigh bone and hip joint with prosthesis | 13 | $1,687 | $120 |
| New patient visit (30+ min) | 19 | $1,429 | $75 |
| Short return visit (20+ min) | 19 | $1,046 | $50 |
| X-ray of knee, 1-2 views | 25 | $608 | $23 |
| X-ray of hip, 2-3 views | 15 | $450 | $28 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $86 | None |
Medicaid work
$1,787 in 2019
Medicaid paid $1,787 for 15 billed services this clinician did in 2019, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 15 | $1,787 |
| 2019 | 15 | 1 | 12 | $1,787 |
| 2018 | 104 | 4 | 15 | $6,857 |
See the largest Medicaid services in earlier years
2018
| Return visit (30+ min) | 62 | $4,437 |
| New patient visit (30+ min) | 14 | $1,402 |
| DRAIN/INJ JOINT/BURSA W/US | 13 | $916 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 15 | $102 |
Drugs they prescribed that Part D paid
$20,808
Pharmacies billed $20,808 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 22% of their Part D prescriptions (154 of 697) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%.
682 generic and 15 brand-name prescriptions · $20,808 in drug cost · 59 antibiotic prescriptions to 51 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 13 | $7,890 | $607 |
| Enoxaparin | 88 | $6,458 | $69 |
| Naloxone | 51 | $3,133 | $61 |
| Celecoxib | 20 | $953 | $40 |
| Oxycodone | 102 | $943 | $7 |
See all 10 drugs
| Eliquis | 13 | $7,890 | $607 |
| Enoxaparin | 88 | $6,458 | $69 |
| Naloxone | 51 | $3,133 | $61 |
| Celecoxib | 20 | $953 | $40 |
| Oxycodone | 102 | $943 | $7 |
| Meloxicam | 108 | $305 | $2 |
| Pantoprazole | 80 | $285 | $3 |
| Cephalexin | 42 | $189 | $4 |
| Hydrocodone-Acetaminophen | 12 | $140 | $10 |
| Ondansetron | 56 | $115 | $2 |
Year by year
| 2024 | 697 | 199 | 22% (154) | 2% | $20,808 |
| 2023 | 331 | 123 | 27% (88) | None | $9,819 |
| 2022 | 460 | 149 | 31% (143) | 8% | $14,824 |
| 2021 | 389 | 117 | 33% (130) | 12% | $15,218 |
| 2020 | 320 | 109 | 36% (116) | 13% | $10,348 |
| 2019 | 175 | 96 | 41% (72) | None | $4,834 |
| 2018 | 264 | 130 | 40% (106) | None | $4,409 |
| 2017 | 183 | 92 | 43% (79) | None | $1,318 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Enoxaparin | 48 | $3,354 | $70 |
| Naloxone | 33 | $2,696 | $82 |
| Oxycodone | 74 | $742 | $10 |
| Pantoprazole | 43 | $229 | $5 |
| Meloxicam | 58 | $179 | $3 |
| Cephalexin | 15 | $97 | $6 |
2022: 11 drugs
| Enoxaparin | 52 | $4,041 | $78 |
| Naloxone | 30 | $2,938 | $98 |
| Celecoxib | 60 | $2,352 | $39 |
| Oxycodone | 106 | $781 | $7 |
| Diclofenac | 21 | $554 | $26 |
| Pantoprazole | 60 | $426 | $7 |
| Hydrocodone-Acetaminophen | 20 | $233 | $12 |
| Cephalexin | 16 | $138 | $9 |
| Amoxicillin | 17 | $58 | $3 |
| Meloxicam | 13 | $58 | $4 |
| Tramadol | 14 | $48 | $3 |
2021: 8 drugs
| Narcan | 35 | $4,732 | $135 |
| Enoxaparin | 49 | $3,705 | $76 |
| Celecoxib | 43 | $1,797 | $42 |
| Oxycodone | 86 | $656 | $8 |
| Diclofenac | 19 | $430 | $23 |
| Pantoprazole | 46 | $261 | $6 |
| Cephalexin | 13 | $130 | $10 |
| Tramadol | 30 | $88 | $3 |
2020: 9 drugs
| Enoxaparin | 39 | $3,493 | $90 |
| Narcan | 26 | $3,382 | $130 |
| Celecoxib | 24 | $791 | $33 |
| Oxycodone | 84 | $739 | $9 |
| Diclofenac | 16 | $442 | $28 |
| Cephalexin | 31 | $245 | $8 |
| Pantoprazole | 24 | $111 | $5 |
| Hydrocodone-Acetaminophen | 11 | $107 | $10 |
| Tramadol | 16 | $78 | $5 |
2019: 5 drugs
| Oxycodone | 43 | $278 | $6 |
| Cephalexin | 28 | $215 | $8 |
| Tramadol | 18 | $79 | $4 |
| Pantoprazole | 12 | $61 | $5 |
| Meloxicam | 16 | $60 | $4 |
2018: 4 drugs
| Oxycodone | 80 | $491 | $6 |
| Cephalexin | 59 | $330 | $6 |
| Pantoprazole | 26 | $161 | $6 |
| Meloxicam | 16 | $62 | $4 |
2017: 5 drugs
| Oxycodone | 45 | $323 | $7 |
| Oxycodone-Acetaminophen | 19 | $174 | $9 |
| Pantoprazole | 25 | $148 | $6 |
| Cephalexin | 33 | $139 | $4 |
| Meloxicam | 18 | $67 | $4 |
Money from drug and device companies
$130 in 2024
A payment is not proof that care is biased.
| Stryker | Mako | $130 | 1 payment
|
See the published payment
| Stryker | Meals · 2024-01-13 | Mako | $130 |
Professional record
- NPI
- 1053763284
- Licence
- CA PA56705, RI PA00892
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X); Physician assistant, surgical (363AS0400X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2016-07-12
- NPI last updated
- 2025-12-23
- NPI record certified
- 2025-12-23
This is when the NPI record was last certified, not a medical board exam.